Role of Saindhavadya Anjana and Carboxy Methyl Cellulose eye drop with Jeevaniya Taila Nasya for treating Shushkakshipaka with special reference to Computer Vision Syndrome

A randomized comparative clinical trial on the efficacy of Saindhavadya Anjana and Carboxy Methyl Cellulose eye drop each combined with Jeevaniya Taila Nasya in the management of Shushkakshipaka with special reference to Computer Vision Syndrome

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093845

Enrollment

100

Registered

2025-08-28

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H539- Unspecified visual disturbance

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients between 18 to 55 years of age and willing to participate in this study through written consent are recruited. 2.Patients utilizing a Computer or Video Display Terminals VDTs for a minimum of two hours each day and presenting with minimum three of clinical features of Shushkakshipaka Computer Vision Syndrome such as Kunita Vartma Photophobia, Avila Darsana Blurring of vision, Gharsa Foreign body sensation, Toda Asthenopia, Ushnadaha Burning sensation, Vishushkatva Dryness of eyes, Raga Conjunctival congestion. 3.Patients with OSDI score from Mild 13 to 22 to Moderate 23 to 32 will be included in the study.

Exclusion criteria

Exclusion criteria: 1.Individuals under the age of 18 and those over the age of 55 are not included in the study. 2.Cases that are complicated by Acute or Chronic infection of Conjunctiva, Eyelid, Cornea, Dacryocystitis, Lagophthalmos, Sjogrens Syndrome. 3.Pregnant and lactating women are excluded in the study. 4.Patients with severe systemic illnesses that could hamper the trial in between are excluded. 5.Severe patients of Computer Vision Syndrome with complications like Corneal Ulcer.

Design outcomes

Primary

Measure	Time frame
Changes in Ocular Surface Disease Index (OSDI) score in Shushkakshipaka (Computer Vision Syndrome).Timepoint: Improvement in OSDI score from baseline to the end of 33 days treatment period, indicating relief in Shushkakshipaka (Computer Vision Syndrome).	—

Secondary

Measure	Time frame
Changes in Schirmer-1 reading, Tear Film Break-Up Time, Ocular Surface Staining grading and subjective Ocular symptoms grading in Shushkakshipaka (Computer Vision Syndrome).Timepoint: Improvement in Schirmer-1 reading, Tear Film Break-Up Time, Ocular Surface Staining grading and subjective Ocular symptoms grading from baseline to the end of 33 days treatment period, indicating relief in Shushkakshipaka (Computer Vision Syndrome).	—

Measure

Time frame

Changes in Schirmer-1 reading, Tear Film Break-Up Time, Ocular Surface Staining grading and subjective Ocular symptoms grading in Shushkakshipaka (Computer Vision Syndrome).Timepoint: Improvement in Schirmer-1 reading, Tear Film Break-Up Time, Ocular Surface Staining grading and subjective Ocular symptoms grading from baseline to the end of 33 days treatment period, indicating relief in Shushkakshipaka (Computer Vision Syndrome).

—

Countries

India

Contacts

Public ContactDr Mahima Choudhary

National Institute of Ayurveda Deemed to be University (De-novo) Jaipur

pamnani.gulab@gmail.com9461154942

Outcome results